A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Share:
More In Science
First Supermoon in August on Display Last Night
First Supermoon in August on Display Last Night
August Offers Rare Glimpse at Two Supermoons
August Offers Rare Glimpse at Two Supermoons
Brain Fog and Other Long COVID Symptoms Affect Millions
The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions.
Amazon Launches Clinic Services in 50 States
Amazon Launches Telehealth Service Across U.S.
Thermo Fisher Scientific Settles With Family of Henrietta Lacks
More than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells without her knowledge, a lawyer for her descendants said they have reached a settlement with a biotechnology company that they accused of reaping billions of dollars from a racist medical system.
Worm Survives 46,000 Years Frozen in Permafrost
Scientists have discovered a worm that lived alongside the woolly mammoths and has been frozen for about 46,000 years in Siberian permafrost.
NASA Loses Contact With Voyager 2
NASA has lost contact with a spacecraft that's been exploring space since 1977.
Georgia Nuclear Reactor Begins Operating
The first American nuclear reactor built from scratch in decades has started operations.
CDC: Leprosy Cases Surge in Central Florida
Cases of leprosy have been on the rise in central Florida, according to the CDC.
